openPR Logo
Press release

Beginning of the bloom: The Rise of the Pneumonia Treatment Drugs Market 2021-2025 | International Company’s - GSK, MSD, Mylan, Novartis, Pfizer, Teva, AstraZeneca, Sun Pharma

04-02-2021 12:03 PM CET | Health & Medicine

Press release from: Business Industry Reports

Pneumonia Treatment Drugs Market

Pneumonia Treatment Drugs Market

All information provided in the report is derived from trusted industrial sources. Global Pneumonia Treatment Drugs Market research reports finds market figures between 2021 and 2025. The market will exhibit remarkable CAGRs in the aforementioned period.

Overview of Global Pneumonia Treatment Drugs Market:

This report studies the Global Pneumonia Treatment Drugs Market over the forecast period of 2020 to 2025. The Global Pneumonia Treatment Drugs Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.

As per the market research study, Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affects over 450 million people across the globe and results in four million deaths every year. Nowadays, the Pneumonia Treatment Drugs Market is witnessing extensive research and development activities and a significant number of new product launches. This encourages manufacturers to cater to the increasing demand from customers.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/193115 .

Increasing number of on-going clinical trials for the development of drug molecules will have a significant impact on the market progression. As per the WHO, the most common cause of pneumonia in children is Streptococcus pneumoniae. In 2017, around 808,694 children under the age of 5 were died due to pneumonia and it accounts for approximately 15% of death cause in children.

The Global Pneumonia Treatment Drugs Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Pneumonia Treatment Drugs Market is sub-segmented into Macrolides, Cephalosporin, Penicillin, Tetracyclines, Fluoroquinolones and others. On the basis of Application, the Global Pneumonia Treatment Drugs Market is classified into Hospital, Clinic, Drugstore and others.

In terms of the geographic analysis, North America dominates the global market and the trend is expected to continue during the forecast period. APAC is expected to hold the second-largest share of the Global Pneumonia Treatment Drugs Market during the forecast period, due to high incidence of pneumonia in countries such as China and India.

Global Pneumonia Treatment Drugs Market Objectives:

1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Pneumonia Treatment Drugs Market

2 To analyze and forecast the size of the Pneumonia Treatment Drugs Market, in terms of value and volume

3 To analyze opportunities in the Pneumonia Treatment Drugs Market for stakeholders and provide a competitive landscape of the market

4 To define, segment, and estimate the Pneumonia Treatment Drugs Market based on deposit type and end-use industry

5 To strategically profile key players and comprehensively analyze their market shares and core competencies

6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market

7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America

8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Pneumonia Treatment Drugs Market

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Pneumonia Treatment Drugs Market Report 2021” @ https://www.businessindustryreports.com/buy-now/193115/single .

Top Leading Key Manufacturers are: GlaxoSmithKline, MSD, Mylan, Novartis, Pfizer, Teva Pharmaceutical, Arsanis, AstraZeneca, Combioxin, Shinogi, Sun Pharmaceutical, Medicines, Theravance Biopharma and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Global Medical Industry News:

GlaxoSmithKline (GSK) (March 29, 2021) - GSK to support manufacture of Novavax’ COVID-19 vaccine - GSK has reached an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support manufacturing of up to 60 million doses of Novavax’ COVID-19 vaccine candidate (NVX-CoV2373) for use in the UK. GSK will provide ‘fill and finish’ manufacturing capacity at its Barnard Castle facility in the North East of England beginning as early as May 2021, with a rapid technology transfer between the two companies beginning immediately. The parties will negotiate a final agreement to include additional terms and conditions.

The UK Government has secured 60 million doses of the vaccine under an advance purchase agreement with Novavax. The protein antigen component of NVX-CoV2373 is also produced in the North East of England by Novavax’ manufacturing partner, FUJIFILM Diosynth Biotechnologies, at their site in Billingham, Stockton-on-Tees.

Fill and finish, to be provided by GSK, is the completion stage of vaccine manufacturing, preparing vials of the final vaccine and packaging them for distribution and use. The GSK site at Barnard Castle, which will deliver the vaccine doses under this collaboration, is a specialised facility in GSK’s global manufacturing network, which supports production of GSK pharmaceutical and vaccine products.

Roger Connor, President, GSK vaccines, said: “GSK is delighted to support Novavax and the UK Vaccines Taskforce with this manufacturing arrangement for the UK and our Barnard Castle facility is now undertaking the rapid preparation work required to manufacture up to 60m doses of this vaccine. We have ensured that we can deliver these volumes without impacting supply of our other vital medicines and vaccines, and without disruption to the other COVID-19 collaborations GSK is engaged in globally.”

“This partnership with GSK continues the expansion of our global supply network, which we expect to increase overall production capacity and, if approved by regulatory agencies, support access to a potentially important new vaccine against COVID-19,” said Rick Crowley, Executive Vice President and Chief Operations Officer, Novavax. “We thank the UK government’s Vaccine Taskforce for its instrumental role in ensuring the progress of our COVID-19 vaccine, from both a clinical and now manufacturing perspective, as well as GSK for making their facilities available to help fight the pandemic.”

Prime Minister Boris Johnson said: “I’m delighted by GSK’s investment, which shows the strength of UK manufacturing, and will further boost our vaccine rollout. The Vaccines Taskforce has worked hand in glove with business to successfully deliver vaccines to the whole of the UK, and this agreement will continue to support our approach. We remain on track to offer a first jab to all over 50s by 15 April, and all adults by the end of July, and I want to once again encourage everyone to come forward for a vaccine when you’re called.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/193115 .

Major Points in Table of Contents:

Global Pneumonia Treatment Drugs Market Report 2021

1 Pneumonia Treatment Drugs Product Definition

2 Global Pneumonia Treatment Drugs Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Pneumonia Treatment Drugs Shipments

2.2 Global Manufacturer Pneumonia Treatment Drugs Business Revenue

2.3 Global Pneumonia Treatment Drugs Market Overview

3 Manufacturer Pneumonia Treatment Drugs Business Introduction

3.1 GlaxoSmithKline Pneumonia Treatment Drugs Business Introduction

3.2 MSD Pneumonia Treatment Drugs Business Introduction

3.3 Mylan Pneumonia Treatment Drugs Business Introduction

3.4 Novartis Pneumonia Treatment Drugs Business Introduction

3.5 Pfizer Pneumonia Treatment Drugs Business Introduction

3.6 Teva Pharmaceutical Pneumonia Treatment Drugs Business Introduction

………………. Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Beginning of the bloom: The Rise of the Pneumonia Treatment Drugs Market 2021-2025 | International Company’s - GSK, MSD, Mylan, Novartis, Pfizer, Teva, AstraZeneca, Sun Pharma here

News-ID: 2265368 • Views: 497

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Pneumonia

Global Pneumonia Therapeutics Market 2018 – 2023
Global Pneumonia Therapeutics Market 2018–2023 Poised for xx% Growth Planet Market Research has recently added a market study named Global Pneumonia Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023 with prime importance on the forecast period from 2018 to 2023. The report is an in-depth analysis of the market for pneumonia therapeutics and covers various driving factors, restraints, opportunities and challenges affecting the market’s growth. Pneumonia is an
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets. Report Consultant has introduced a new report titled as Global Pneumonia
Pneumonia Testing Market Opportunity Analysis, 2018-2026
Pneumonia is a lung infection caused by bacteria, viruses or fungi, primarily affecting the small sir sacs known as alveoli. The most common bacterial type that causes pneumonia is Streptococcus pneumoniae. The symptoms for pneumonia include, fever, chills, cough, shortness of breath and fatigue. To detect whether, a person has pneumonia are blood tests, chest X-ray, pulse oximetry, and Sputum test. Further, if the patients is older than age 65,
Pneumonia Diagnostics Market worth US$ 685 Mn by 2027
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Pneumonia Drug Development Pipeline Review, 2017
This report provides an overview of the pipeline landscape for pneumonia disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Community Acquired Pneumonia, Hospital Acquired Pneumonia and Ventilator Associated Pneumonia and features dormant and discontinued projects. Summary Community acquired pneumonia is pneumonia contracted by a person who has had little contact with the healthcare system, with common symptoms including cough, fever and
Pneumonia Vaccine Market- GlaxoSmithKline, Pfizer, Merck
Global Pneumonia Vaccine Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Pneumonia Vaccine Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GlaxoSmithKline Pfizer Merck Enquiry for buying report @ https://goo.gl/793aS1 The Global Pneumonia Vaccine report gives a thorough situation of the present and gauge Pneumonia Vaccine showcase procedures, improvement methodologies and development openings.